Nature of Operations and Basis of Presentation (Tables)

6 Months Ended

Jun. 30, 2021

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Schedule of Effect of Error Correction on Previously Issued Financial Statements

The Company also adjusted for other immaterial corrections for the three and six months ended June 30, 2021. The following table presents the effect of the error correction on the Company’s unaudited condensed interim balance sheet as of June 30, 2021, unaudited condensed interim statement of operations for the three and six months ended June 30, 2021, and unaudited condensed interim statement of cash flows for the six months ended June 30, 2021.

	Three Months Ended June 30, 2021									Six Months Ended June 30, 2021
	As Previously Reported			Correction of Error			As Restated			As Previously Reported			Correction of Error			As Restated
Changes in the balance sheet:
Deferred collaboration funding, short-term	$	19,251,394		$	2,939,898		$	22,191,292
Total current liabilities		32,207,156		$	2,939,898			35,147,054
Total liabilities		32,207,156		$	2,939,898			35,147,054
Accumulated deficit		(103,876,405	)	$	(2,939,898	)		(106,816,303	)
Total stockholders' equity		7,777,036		$	(2,939,898	)		4,837,138
Changes in the statement of operations:
Revenue		—			—			—		$	3,998,133		$	(3,098,133	)	$	900,000
Research and development		1,460,975			(99,688	)		1,361,287			3,466,880			(99,688	)		3,367,192
General and administrative		2,327,055			(58,547	)		2,268,508			5,841,196			(58,547	)		5,782,649
Total operating expenses		3,788,030			(158,235	)		3,629,795			9,308,076			(158,235	)		9,149,841
Loss from operations		(3,788,030	)		158,235			(3,629,795	)		(5,309,943	)		(2,939,898	)		(8,249,841	)
Net loss		(3,227,272	)		158,235			(3,069,037	)		(4,740,444	)		(2,939,898	)		(7,680,342	)
Net loss per share - basic and diluted		(0.23	)		0.02			(0.21	)		(0.33	)		(0.21	)		(0.54	)
Research and development collaboration funding offset		926,247			99,688			1,025,935			1,212,350			99,688			1,312,038
General and administrative collaboration funding offset		543,987			58,547			602,534			543,987			58,547			602,534
Changes in the statement of cash flows:
Net loss											(4,740,444	)		(2,939,898	)		(7,680,342	)
Deferred collaboration funding, short-term											15,251,394			2,939,898			18,191,292